| Video
Dr. Ziegler comments on the importance of documenting best practice compliance in today's environment of intense scrutiny and litigiousness. There are steps that clinicians can take today, and ways that they can influence the future of regulation and reimbursement.
| Video
In the area of accepted standards of prescribing practice, do you know what law enforcement is looking for? Dr. Gonzalez offers pointers from his "Pain practice checkup" presented at PAINWeek 2017. Good information to keep you in the know!
| Video
Providers who do not understand medical necessity for drug testing, controlled medication prescribing, and substance abuse treatment are at risk as payers increasingly scrutinize these areas. Attorney Jennifer Bolen outlines some "pearls and pitfalls" for clinicians. Watch for important tools you...
| Video
Too often, prescribers are the last to learn of an overdose event and worse, fail to take action once notified. Attorney Bolen outlines policies and protocols that practitioners can implement to proactively signal their intent to get things right when they go wrong.
| Article
Fewer than 5% of people who are referred for treatment for opioid abuse from the criminal justice system in the US are receiving medication assisted therapy. This finding is reported by researchers from Johns Hopkins Bloomberg School of Public Health in a study report appearing in the December...
| Video
Michael C. Barnes, an attorney who practices law with DCBA Law and Policy in Washington DC, discusses the nonadherent patient and recommends what a practitioner should do for the patient, and for themselves.
| Video
At PAINWeek we look at topics from all sides. Here, Michael C. Barnes, an attorney who practices law with DCBA Law and Policy in Washington DC, gives his opinion on the opioid controversy, and what practitioners and patients should think about as Plan B.
| Video
The legal landscape for prescribers of controlled medications for pain and addiction is fraught with risk. Attorney Michael Barnes outlines best practices for prescribing clinicians to protect their patients from harm and themselves from criminal and civil liability.
| Article
To date, medical marijuana has been legalized in 29 states plus the District of Columbia, with chronic pain and/or HIV/AIDS as qualifying conditions for treatment. But little is known about the impact of medical marijuana on opioid use in patients with chronic pain, including the at-risk for opioid...
| Video
Public policy reaction to the opioid crisis has significant implications for practitioners and their patients with pain. Attorney Michael Barnes looks at the current federal and state-level regulatory picture, and at some benefits, drawbacks, and unintended consequences of regulatory response.